SCHEMBL4184540

SCHEMBL4184540

N#Cc1cc(-c2ccc(C(=O)NNc3cc(Cl)ccc3Cl)o2)ccc1F

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 7/20 0.47
RPA1 P27694 1/20 0.45
S1PR4 O95977 2/20 0.43
ALDH1A1 P00352 5/20 0.42
NPC1 O15118 3/20 0.42
RAB9A P51151 2/20 0.42
HPGD P15428 3/20 0.41
KDM4E B2RXH2 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
MEN1 O00255 1/20 0.41
TP53 P04637 1/20 0.41
ALOX15 P16050 1/20 0.41
TSHR P16473 1/20 0.41
HTT P42858 1/20 0.41
KMT2A Q03164 1/20 0.41
HSD17B10 Q99714 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
HTR1A P08908 1/20 0.40
ADORA3 P0DMS8 1/20 0.40
CNR1 P21554 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL922038 0.75 RPA1 (0.63) RPA1ALDH1A1HPGDKDM4EMEN1
SCHEMBL4174561 0.73 JAK2 (0.55) GAAS1PR4ALDH1A1KMT2A
SCHEMBL4182153 0.71 NPC1 (0.63) GAAALDH1A1NPC1RAB9AHPGD
SCHEMBL1180133 0.68 RPA1 (0.42) RPA1ALDH1A1HPGDKDM4ESMN1; SMN2
SCHEMBL1180189 0.68 RPA1 (0.42) RPA1ALDH1A1KDM4ESCN10A
SCHEMBL4631024 0.65 CNR2 (0.43) RPA1
SCHEMBL4896592 0.64 ALDH1A1 (0.55) ALDH1A1NPC1RAB9AHPGDKDM4E
SCHEMBL110247 0.63 AHR (0.52) S1PR4ALDH1A1HPGDKDM4EMEN1
SCHEMBL3055514 0.63 RPA1 (0.78) GAARPA1ALDH1A1NPC1RAB9A
SCHEMBL19556314 0.63 RPA1 (0.78) RPA1ALDH1A1HPGDKDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090036508-A1 AMINO INDAZOLE DERIVATIVES MERCK PATENT GMBH (DE) 2009-02-05 US disclosed
US-20090036508-A1 AMINO INDAZOLE DERIVATIVES MERCK PATENT GMBH (DE) 2009-02-05 US disclosed
US-20090036508-A1 AMINO INDAZOLE DERIVATIVES MERCK PATENT GMBH (DE) 2009-02-05 US disclosed
WO-2007090494-A1 AMINO INDAZOLE DERIVATIVES MERCK PATENT GMBH (DE) 2007-08-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090036508-A1 AMINO INDAZOLE DERIVATIVES CHEK1, CHEK2, SGK3 GAA 3878/4885RPA1 430/4885S1PR4 3995/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.